Dorsavi Renews DoD-Backed Contract to Cut Stress Fractures in Military Training
dorsaVi renews DoD-backed military injury research contract with Georgia Southern University
dorsaVi Limited (ASX: DVL) has renewed its ongoing 12-month research agreement with Georgia Southern University (GSU), funded by the U.S. Department of Defense (DoD), targeting a reduction in stress fracture injuries among military trainees in load-bearing field environments. The renewal represents active commercial validation of the company’s “Intelligence at the Ultra-Edge” strategy, deploying FDA-cleared wearable sensors in real-world defence settings rather than controlled laboratory conditions.
Key highlights of the renewed agreement include:
- 12-month renewal of the research agreement with GSU, with the study funded by the U.S. Department of Defense
- Target outcome: reduction of stress fracture injuries among military trainees in load-bearing field environments
- dorsaVi sensors to monitor gait and running patterns in the field, not on a treadmill
- Real-time biofeedback delivered to trainees aimed at lowering tibial shock and preventing injury before it occurs
- Methodology protected by two granted U.S. patents
- No material costs to dorsaVi under the agreement
Matthew Regan, Group Chief Executive Officer
“We are excited to continue the project with the clinical team at GSU, who have been exceptional to work with. We are confident that delivering these biomechanical insights to runners in real time will enable meaningful technique improvements, reducing the risk of stress fractures and lower limb injuries. This research is transferable to all runners, particularly those in remote environments where technique feedback has simply not been available before.”
When big ASX news breaks, our subscribers know first
Understanding the military’s stress fracture problem — and why wearable tech is the answer
The injury that sidelines soldiers for months
Stress fractures rank among the most prevalent training injuries in military organisations globally, occurring most frequently during load-bearing runs on hard surfaces. Once sustained, a stress fracture in the foot, tibia, or femur typically sidelines personnel for between 6 and 18 weeks, depending on severity and location, creating a direct and measurable impact on operational continuity and readiness.
The clinical basis for the GSU study’s approach is well established. Peer-reviewed research published in Nature (2021) demonstrated that runners can modify their technique in real time, specifically by reducing ground impact forces, when provided with appropriate biofeedback. The GSU study takes this evidence base out of the laboratory and deploys it in field conditions.
What dorsaVi’s sensors actually measure
dorsaVi’s FDA-cleared wearable sensors capture vertical accelerometer data at up to 1,125Hz, enabling real-time computation of five biomechanical metrics directly correlated to injury risk:
- Initial Peak Acceleration (IPA): The primary correlate of tibial shock, and the key metric driving the study’s biofeedback intervention
- Ground Reaction Force (GRF): Measures the force exerted on the ground at foot strike, providing a direct indicator of impact load
- Ground Contact Time (GCT): Tracks how long the foot remains on the ground per stride; symmetry is a critical indicator of gait health
- Cadence: Steps per minute; approximately 180 steps per minute is the established benchmark for elite and sub-elite runners
- Foot Strike Pattern: Classifies the runner as a forefoot, midfoot, or rear-foot striker, a key variable in injury risk profiling
| Metric | What It Measures | Injury Risk Link | Why It Matters for Military | Captured by DVL Sensors |
|---|---|---|---|---|
| Initial Peak Acceleration (IPA) | Vertical acceleration at foot strike | Primary correlate of tibial shock | High IPA directly linked to stress fracture incidence in load-bearing trainees | Yes |
| Ground Reaction Force (GRF) | Force exerted on ground at foot strike | Elevated impact load increases fracture risk | Indicates whether training loads are within safe thresholds for each individual | Yes |
| Ground Contact Time (GCT) | Duration foot remains on ground per stride | Asymmetry indicates compensatory movement | Detects gait degradation under fatigue during field training | Yes |
| Cadence | Steps per minute | Lower cadence associated with higher impact forces | Optimising cadence toward ~180 steps/min reduces injury exposure | Yes |
| Foot Strike Pattern | Forefoot, midfoot, or rear-foot classification | Rear-foot striking linked to greater tibial shock | Profiles individual injury risk for targeted biofeedback intervention | Yes |
Importantly, dorsaVi retains raw 1,125Hz data across close to all subjects, accumulated across thousands of runners over more than a decade. This proprietary dataset creates a compounding data flywheel that continuously refines the company’s AI models, increasing both the accuracy and commercial value of its intellectual property over time.
From field study to exoskeletons — the strategic bridge
The same data that prevents fractures can power a robotic exoskeleton
The core challenge at the heart of the GSU study — capturing high-fidelity human movement data in an uncontrolled field environment, processing it at the ultra-edge in real time, and translating it into an actionable signal that modifies behaviour in the moment — is identical to the intelligence problem facing next-generation exoskeleton control systems.
Metrics including Ground Contact Time, peak acceleration, cadence asymmetry, and force distribution are precisely the variables an exoskeleton’s control system requires to synchronise with human gait, detect fatigue-induced movement degradation, and prevent both human injury and mechanical failure. Critically, no new foundational R&D is required; this strategic expansion activates capabilities dorsaVi already possesses or is actively developing.
Three commercial application pathways
dorsaVi is formally exploring commercial opportunities across three high-value application areas:
- Exoskeleton Intelligence Layer: DVL sensors embedded in exoskeleton systems as the real-time movement intelligence layer, providing adaptive gait control, joint tracking, and force feedback to actuators. Pursued via a licensing and OEM partnership model as a fast path to revenue.
- Human-in-the-loop Robot Control: Closed-loop human-robot systems using neuromorphic edge processing, where the exoskeleton responds to the human and the human guides the robot, within mathematically guaranteed safety boundaries. Targets defence and industrial applications.
- Fatigue-Aware Robotics: Motion analytics detecting fatigue patterns and asymmetric loading in real time, enabling the exoskeleton to automatically adjust assistance based on the wearer’s physical state. Addresses mandatory workplace safety compliance requirements globally and creates a continuous data flywheel for AI improvement.
The RRAM neuromorphic advantage
Neuromorphic computing mimics the architecture of the human brain, processing information in parallel, learning and adapting at the ultra-edge, and operating at minimal power levels without relying on cloud connectivity. For exoskeleton applications, this addresses the primary limitation of current systems: their dependence on power-hungry, latency-prone conventional processors.
Following the recently completed acquisition of neuromorphic and in-memory processing IP from one of the world’s foremost research universities in electrical engineering and nanotechnology, dorsaVi has commenced discussions with strategic partners and venture capital firms in Israel to progress commercialisation. The four enabling capabilities this program provides are:
- On-body real-time processing: Sensor fusion, safety calculations, and adaptive control algorithms run directly on the exoskeleton, with no cloud round-trip required
- Ultra-low power consumption: RRAM-based neuromorphic chips operate at a fraction of the power of conventional processors, which is critical for battery-powered wearable systems
- Continuous edge learning: The neuromorphic architecture enables the processor to adapt to individual wearers over time, improving control precision and safety
- Vertically integrated compute and sensing stack: DVL’s neuromorphic chip combined with its proprietary sensor intelligence creates a purpose-built platform for human augmentation and collaborative robotics
The next major ASX story will hit our subscribers first
Defence pedigree, patents, and a platform built for scale
Credibility built in mission-critical environments
dorsaVi’s engagement with U.S. government-backed programmes predates the current GSU study. Prior DoD-funded work included capturing G-force data from U.S. fighter pilots, establishing the company’s credibility in mission-critical defence applications. The GSU renewal is not a new relationship but a continuation of an active programme, reflecting sustained confidence from a U.S. government-backed research initiative.
The GSU methodology is protected by two granted U.S. patents covering dorsaVi’s approach to injury reduction through gait modification, providing a defensible intellectual property position as the platform scales.
The market opportunity ahead
dorsaVi’s sensor intelligence platform is positioned to address four distinct and growing market segments:
- Defence and Military: Soldier augmentation, load-carrying, and endurance enhancement; major programmes active across the US, EU, and Asia-Pacific, with safety-certified human augmentation a critical procurement requirement
- Industrial and Construction: Musculoskeletal injury reduction in heavy manual work, with workplace safety compliance driving adoption globally
- Rehabilitation and Healthcare: Powered exoskeletons for stroke recovery, spinal cord injury rehabilitation, and mobility assistance, with sensor-driven adaptive control as the key differentiator
- Aged Care: Assistive exoskeletons for elderly populations across Asia-Pacific, a policy-supported and high-growth market aligned with dorsaVi’s geographic strengths
The broader human-robot collaboration ecosystem, encompassing collaborative robots, autonomous mobile robots, and surgical robotics, represents a combined addressable market of USD 100 billion, according to the company’s ASX Announcement dated 28 April 2026.
Matthew Regan, Group Chief Executive Officer
“The GSU study is the proof of concept for everything that follows. We are not conducting a research project, we are field-testing a platform under some of the most demanding conditions imaginable, with DoD backing. The same sensor intelligence being used to prevent stress fractures in military trainees is the intelligence layer that a powered exoskeleton, a cobot, or an autonomous defence system needs to operate safely alongside a human being. By integrating our gold-standard motion data with our neuromorphic and RRAM architecture, we are giving robotics a digital nervous system. We are shifting from being a sensor company to providing the essential intelligence layer that allows advanced machinery to synchronise with human intent — and that is a very different, and considerably larger, business.”
Don’t Miss the Next Healthcare Breakout Stock
Big News Blast delivers FREE breaking ASX healthcare and tech news directly to your inbox within minutes of release, complete with in-depth analysis already done for you. Join 20,000+ subscribers who stay ahead of the market the moment announcements drop. Click the “Free Alerts” button to start receiving real-time coverage today.